相关实验视频

Updated: May 6, 2026

Manufacture of Concentrated, Lipid-based Oxygen Microbubble Emulsions by High Shear Homogenization and Serial Concentration

Manufacture of Concentrated, Lipid-based Oxygen Microbubble Emulsions by High Shear Homogenization and Serial Concentration

Published on: May 26, 2014

氧气敏感药物释放使用血红蛋白微泡:在超声中介药物输送中针对低氧的新方法

Ghazal Rastegar¹, Mohammad Musa Salman¹, Shashank R Sirsi¹

¹Department of Bioengineering, Erik Johnson School of Engineering, The University of Texas at Dallas, Richardson, TX 75080, USA.

International journal of pharmaceutics

|March 26, 2025

概括

这项研究引入了与多克索鲁比载脂体结合的血红蛋白微泡 (HbMBs),用于向药物输送. 这些新型的Lipo-HbMBs在低氧环境中释放药物的数量显著增加,非常适合缺氧瘤.

科学领域:

生物医学工程生物医学工程
药物输送系统药物输送系统
在瘤学瘤学.

背景情况:

聚焦超声波 (FUS) 可实现精确的,深层组织药物输送.
超声波对比剂 (UCAs) 增强了FUS的能力.
低毒瘤微环境对向治疗构成了挑战.

研究的目的:

开发一种新型的低氧向药物输送系统,使用与多克索鲁比载脂质体 (LDOX) 结合的血红蛋白微泡 (HbMBs).
在聚焦超声波暴露下,研究开发的脂-HbMB复合物的氧敏感药物释放特性.

主要方法:

将多克索鲁比载脂体 (LDOX) 结合在血红蛋白微泡 (HbMB) 上,形成脂-HbMB 复合体.
脂-HbMB复合物的暴露在不同氧气部分压力 (pO₂) 的聚焦超声波下.
基于声响应和氧气水平的多克索鲁比辛释放量的量化.

主要成果:

脂-HbMB复合体在低氧条件下 (低氧) 显示出显著更高的多克索鲁比辛释放量.
药物释放量在5mmHg pO₂时大约是10倍,而在160mmHg pO₂时大约是10倍.
该系统展示了超声波介导的,对氧气敏感的药物解锁.

结论:

开发的Lipo-HbMB复合体显示出使用聚焦超声波对低氧瘤进行向药物输送的显著潜力.
这是第一次报告超声波介导的氧气敏感药物开封,增强FUS的特异性.
该技术提供了一种有前途的方法来应对转移性癌症治疗的挑战.

关键词:

化疗化疗是一种化学疗法.药物输送是药物输送的过程.微气泡是一种微气泡.释放氧气敏感药物的药物.准药物释放的目标超声波超声波是指超声波的使用.

更多相关视频

Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release

Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release

Published on: June 12, 2021

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

相关概念视频

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...